1. 8TH January 2013
DAILY CHARTIST
VIEW

2. HIGHLIGHTS
A
 Highlights
 Nifty showed bearish trend on Monday.
 Nifty Future ended 31.95 points down at 6016.05
 Bharti Airtel sell call we recommended executed today
and is currently trading at cost
 Tata Chemicals sell call remained unexecuted
 Investors’ are advised to hold position in Bharti Airtel
sell call and take position in the fresh call provided
below.
 Sell Bharti Airtel futures below 328.45 for targets
327/325
 Sell Auro Pharma futures below 200 for targets 198/195
 Past Performance:
 Allahabad bank buy call hit both targets.
 Auro Pharma buy call hit 1st target.
 JSW Steel buy call hit both targets.
 Allahabad bank sell call hit both targets.
 Voltas hit both targets
 Adani Enterprise hit target.
 Lupin almost hit 2nd target.
 Havells sell call hit both targets.

3. BHARTI AIRTEL FUTURES – RISING WEDGE
SELL BELOW 328.45 FOR TARGETS 327/325 SL 330.50
BUY ABOVE 250 FOR TARGETS OF 265/285 SL 235
 Bharti Airtel sell we recommended executed today.
 It made a low of 327.65 near to our 1st target 327
 Currently trading at cost at 328.50
 Investors’ are advised to hold the position with
recommended SL
 Targets are 327/325 and SL is recommended at 330.50
 Bharti Airtel is making Rising wedge on hourly chart

4. AURO PHARMA FUTURES– DOUBLE TOP
SELL BELOW 200 FOR TARGETS 198/195 SL 202
 Sell Auro Pharma future below 200
 Auro Pharma is making Double top on hourly chart
 Currently trading at 202.70
 Investors’ are advised to sell below 200 for targets
198/195
 SL is recommended at 367.50
 Auro Pharma is having strong support at 200.50 and
the call may take time in execution.

5. Disclaimer
The information and view in this report, our website & all the service we provide
are believed to be reliable, but we do not accept any responsibility (or liability) for
errors of fact or opinion. Users have the right to choose the product/s that suits
them the most.
Sincere efforts have been made to present the right investment perspective. The
information contained herein is based on analysis and up on sources that we
consider reliable.
This material is for personal information and based upon it & takes no
responsibility
The information given herein should be treated as only factor, while making
investment decision. The report does not provide individually tailor-made
investment advice. Epic research recommends that investors independently
evaluate particular investments and strategies, and encourages investors to seek
the advice of a financial adviser. Epic research shall not be responsible for any
transaction conducted based on the information given in this report, which is in
violation of rules and regulations of NSE and BSE.
The share price projections shown are not necessarily indicative of future price
performance. The information herein, together with all estimates and forecasts, can
change without notice. Analyst or any person related to epic research might be
holding positions in the stocks recommended. It is understood that anyone who is
browsing through the site has done so at his free will and does not read any views
expressed as a recommendation for which either the site or its owners or
anyone can be held responsible for . Any surfing and reading of the information is
the acceptance of this disclaimer.
All Rights Reserved. Investment in equity & bullion market has its own risks.
We, however, do not vouch for the accuracy or the completeness thereof. we are not
responsible for any loss incurred whatsoever for any financial profits or loss
which may arise from the recommendations above epic research does not purport
to be an invitation or an offer to buy or sell any financial instrument. Our Clients
(Paid Or Unpaid), Any third party or anyone else have no rights to forward or
share our calls or SMS or Report or Any other information provided by us to/with
anyone which is related directly or indirectly with them. If found so, then Serious
Legal Actions can be taken.